RenalSense Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 18
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $14M
Latest Deal Amount
  • Investors
  • 4

RenalSense General Information


Developer of a critical care monitoring system designed for real-time renal diagnostics. The company's monitoring system continuously measures urine flow, automatically transmits real-time data about changes in renal function and notifications of fluctuations, on round the clock basis, facilitating doctors with early detection of changes in renal function and acute kidneys injury risk and enabling rapid intervention, better patient care, and improved intensive care unit economics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Primary Office
  • Post Box Office 45397
  • Hamarpe 3, Har Hotzvim
  • Jerusalem 9145101
  • Israel
+972 00-000-0000

RenalSense Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RenalSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 22-Nov-2021 $14M 0000 Completed Generating Revenue
4. Grant 01-Nov-2019 000.00 000 Completed Generating Revenue
3. Grant 30-May-2019 00000 000 Completed Generating Revenue
2. Angel (individual) 01-Jan-2018 $3.5M $8M Completed Generating Revenue
1. Later Stage VC (Series A) 31-Dec-2015 $4.5M $4.5M Completed Generating Revenue
To view RenalSense’s complete valuation and funding history, request access »

RenalSense Patents

RenalSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021514056-A Sensor unit Pending 19-Feb-2018 000000000
EP-3755975-A1 Sensor unit Pending 19-Feb-2018 000000000
US-20200393273-A1 Sensor unit Pending 19-Feb-2018 000000000
JP-6762938-B2 Devices, systems and methods for urine examination Active 22-Dec-2014 00000000
JP-2018508742-A Apparatus, system and method for urinalysis Granted 22-Dec-2014 A61B5/20 00
To view RenalSense’s complete patent history, request access »

RenalSense Executive Team (5)

Name Title Board Seat Contact Info
Avi Kleiman Co-Founder, Chief Executive Officer & Chairman
Yohanan Engelhardt Chief Financial Officer
Moti Barda Chief Operating Officer
Joseph Kochba Vice President, Research & Development
Mor Grinstein Ph.D Co-Founder, Chief Medical Officer & Board Member
To view RenalSense’s complete executive team members history, request access »

RenalSense Board Members (4)

Name Representing Role Since
Avi Kleiman RenalSense Co-Founder, Chief Executive Officer & Chairman 000 0000
Cuong Do Self Board Member 000 0000
Milton Yisrael RenalSense Board Member 000 0000
Mor Grinstein Ph.D RenalSense Co-Founder, Chief Medical Officer & Board Member 000 0000
To view RenalSense’s complete board members history, request access »

RenalSense Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenalSense Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BlueRed Partners Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Israel Innovation Authority Government 000 0000 000000 0
Ministry of Industry, Trade and Communications Government 000 0000 000000 0
To view RenalSense’s complete investors history, request access »